Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Open Angle Glaucoma or Ocular Hypertension”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01594970
What this trial is testing

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 800
Large-scale testing (Phase 3)Study completedNCT01342094
What this trial is testing

DE-111 Against Timolol Ophthalmic Solution 0.5%

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 166
Post-approval studies (Phase 4)Study completedNCT01155219
What this trial is testing

Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.

Who this might be right for
Glaucoma
Laboratoires Thea 150
Early research (Phase 1)Study completedNCT01215786
What this trial is testing

Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 50
Large-scale testing (Phase 3)Study completedNCT02822742
What this trial is testing

A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 26
Not applicableLooking for participantsNCT05039684
What this trial is testing

Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 40
Not applicableStudy completedNCT01628588
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 854
Not applicableActive Not RecruitingNCT05557058
What this trial is testing

GORE Glaucoma Drainage Implant Clinical Study Dominican Republic

Who this might be right for
Primary Open-angle Glaucoma
W.L.Gore & Associates 30
Large-scale testing (Phase 3)Study completedNCT03257813
What this trial is testing

Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratorios Sophia S.A de C.V. 60
Testing effectiveness (Phase 2)Study completedNCT01410188
What this trial is testing

Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Kubota Vision Inc. 160
Testing effectiveness (Phase 2)Study completedNCT02143843
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 75
Testing effectiveness (Phase 2)UnknownNCT03067415
What this trial is testing

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

Who this might be right for
Glaucoma, Primary Open AngleOcular Hypertension
Chong Kun Dang Pharmaceutical 98
Large-scale testing (Phase 3)Study completedNCT01342081
What this trial is testing

DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 489
Large-scale testing (Phase 3)Active Not RecruitingNCT06666855
What this trial is testing

A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 345
Not applicableStudy completedNCT03931317
What this trial is testing

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
University of California, San Diego 70
Not applicableLooking for participantsNCT07390890
What this trial is testing

DSLT for Reducing Medication in Glaucoma

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
The Eye Institute of West Florida 60
Not applicableStudy completedNCT01637246
What this trial is testing

Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 4,385
Large-scale testing (Phase 3)Study completedNCT02059278
What this trial is testing

Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Nephron Pharmaceuticals Corporation 335
Large-scale testing (Phase 3)Study completedNCT05583474
What this trial is testing

OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects

Who this might be right for
Open Angle Glaucoma or Ocular Hypertension
Otsuka Beijing Research Institute 204
Early research (Phase 1)Study completedNCT00515424
What this trial is testing

Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Novartis 90
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation